{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:14:46Z","timestamp":1785413686480,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ratchadapiseksompotch Fund","award":["RA61\/013"],"award-info":[{"award-number":["RA61\/013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The incidence of autoimmune encephalitis has risen globally. There are two general categories of disease-associated antibodies that can be tested for: neuronal surface and intracellular. However, testing both groups of autoantibodies are costly. This study aims to identify differences between groups by comparing clinical presentations, radiological findings and CSF profile of patients, and determine if any parameters are indicative of one group of autoantibodies over another. Additionally, we aim to report the local incidence of less common groups of disease-associated antibodies as well.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seventy-seven records of autoimmune encephalitis\/encephalomyelitis patients admitted to King Chulalongkorn Memorial Hospital, Bangkok, Thailand, between October 2010 and February 2017 were reviewed. Patients with infections or those with classic central nervous system demyelinating features were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 77 patients, 40% presented with neuronal surface antibodies and 33% had intracellular antibodies. The most common autoantibody detected in each group was anti-NMDAr antibody (25\/31, 81%) and anti-Ri antibody (7\/25, 28%) respectively. In the neuronal surface antibody group, behavioral change was the most common complaint (45%), followed by seizures (39%) and abnormal movements (29%). In the latter group, seizure was the most common presenting symptom (32%), followed by motor weakness (20%), behavioural change (16%) and abnormal movements (16%). Patients with neuronal surface antibodies were younger (35 vs 48\u2009years old,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04) and more likely to present with behavioral change (45% vs 16%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02). Mortality rate was higher in the intracellular group (16% vs 3.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.09). No differences were detected in magnetic resonance imaging (MRI) and CSF profile.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In the early stages of the disease, both groups have comparable clinical outcomes. Although there were significant differences in age and percentage of patients with behavioral change, both groups of autoimmune encephalitis still shared many clinical features and could not be distinguished based on MRI and CSF profiles. Therefore, we recommend that patients with features of autoimmune encephalitis should be screened for both the neuronal surface and intracellular antibodies regardless of clinical presentation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-019-1501-5","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T06:02:57Z","timestamp":1573020177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Differences and diversity of autoimmune encephalitis in 77 cases from a single tertiary care center"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0579-5960","authenticated-orcid":false,"given":"Abhinbhen W.","family":"Saraya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanthita","family":"Worachotsueptrakun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritchai","family":"Vutipongsatorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanikarn","family":"Sonpee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiravat","family":"Hemachudha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"issue":"1","key":"1501_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25\u201336.","journal-title":"Ann Neurol"},{"key":"1501_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2377-13-150","volume":"13","author":"A Saraya","year":"2013","unstructured":"Saraya A, Mahavihakanont A, Shuangshoti S, Sittidetboripat N, Deesudchit T, Callahan M, et al. Autoimmune causes of encephalitis syndrome in Thailand: prospective study of 103 patients. BMC Neurol. 2013;13:150.","journal-title":"BMC Neurol"},{"issue":"12","key":"1501_CR3","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s10096-009-0799-0","volume":"28","author":"MS Gable","year":"2009","unstructured":"Gable MS, Gavali S, Radner A, Tilley DH, Lee B, Dyner L, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis. 2009;28(12):1421\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"1501_CR4","first-page":"241","volume":"16","author":"SA MBBS","year":"2011","unstructured":"MBBS SA, Lim S-Y, Goh KJ, Lum LC, Tan CT. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: a series of ten cases from a university hospital in Malaysia. Neurology Asia. 2011;16(3):241\u20136.","journal-title":"Neurology Asia"},{"issue":"1","key":"1501_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","volume":"83","author":"D Dubey","year":"2018","unstructured":"Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018;83(1):166\u201377.","journal-title":"Ann Neurol"},{"key":"1501_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jns.2018.04.009","volume":"390","author":"J Kaneko","year":"2018","unstructured":"Kaneko J, Kanazawa N, Tominaga N, Kaneko A, Suga H, Usui R, et al. Practical issues in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological disorders: 190 cases. J Neurol Sci. 2018;390:26\u201332.","journal-title":"J Neurol Sci"},{"issue":"5","key":"1501_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.4103\/0028-3886.166532","volume":"63","author":"N Kamble","year":"2015","unstructured":"Kamble N, Netravathi M, Saini J, Mahadevan A, Yadav R, Nalini A, et al. Clinical and imaging characteristics of 16 patients with autoimmune neuronal synaptic encephalitis. Neurol India. 2015;63(5):687\u201396.","journal-title":"Neurol India"},{"issue":"Pt 11","key":"1501_CR8","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1093\/brain\/aws256","volume":"135","author":"RC Dale","year":"2012","unstructured":"Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012;135(Pt 11):3453\u201368.","journal-title":"Brain."},{"issue":"10","key":"1501_CR9","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","volume":"85","author":"J Piepgras","year":"2015","unstructured":"Piepgras J, Holtje M, Michel K, Li Q, Otto C, Drenckhahn C, et al. Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons. Neurology. 2015;85(10):890\u20137.","journal-title":"Neurology."},{"issue":"18","key":"1501_CR10","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C, Graus F, Compta Y, Hogl B, Bataller L, Bruggemann N, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology. 2017;88(18):1736\u201343.","journal-title":"Neurology."},{"issue":"24","key":"1501_CR11","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1212\/WNL.0000000000002775","volume":"86","author":"N Gresa-Arribas","year":"2016","unstructured":"Gresa-Arribas N, Planaguma J, Petit-Pedrol M, Kawachi I, Katada S, Glaser CA, et al. Human neurexin-3alpha antibodies associate with encephalitis and alter synapse development. Neurology. 2016;86(24):2235\u201342.","journal-title":"Neurology."},{"issue":"9","key":"1501_CR12","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010;133(9):2734\u201348.","journal-title":"Brain."},{"issue":"1","key":"1501_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9(1):67\u201376.","journal-title":"Lancet Neurol"},{"issue":"24","key":"1501_CR14","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1523\/JNEUROSCI.4415-13.2014","volume":"34","author":"T Ohkawa","year":"2014","unstructured":"Ohkawa T, Satake S, Yokoi N, Miyazaki Y, Ohshita T, Sobue G, et al. Identification and characterization of GABA(a) receptor autoantibodies in autoimmune encephalitis. J Neurosci. 2014;34(24):8151\u201363.","journal-title":"J Neurosci"},{"issue":"3","key":"1501_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","volume":"13","author":"M Petit-Pedrol","year":"2014","unstructured":"Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol. 2014;13(3):276\u201386.","journal-title":"Lancet Neurol"},{"issue":"9","key":"1501_CR16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378(9):840\u201351.","journal-title":"N Engl J Med"},{"issue":"2","key":"1501_CR17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 2017;97(2):839\u201387.","journal-title":"Physiol Rev"},{"issue":"Pt 1","key":"1501_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/brain\/awu310","volume":"138","author":"J Planaguma","year":"2015","unstructured":"Planaguma J, Leypoldt F, Mannara F, Gutierrez-Cuesta J, Martin-Garcia E, Aguilar E, et al. Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain. 2015;138(Pt 1):94\u2013109.","journal-title":"Brain."},{"issue":"6","key":"1501_CR19","first-page":"1653","volume":"23","author":"Eric Lancaster","year":"2017","unstructured":"Lancaster E. Paraneoplastic Disorders. Continuum (Minneap Minn). Neuro-oncology. 2017;23(6):1653\u201379.","journal-title":"CONTINUUM: Lifelong Learning in Neurology"},{"key":"1501_CR20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnmol.2016.00037","volume":"9","author":"MH van Coevorden-Hameete","year":"2016","unstructured":"van Coevorden-Hameete MH, Titulaer MJ, Schreurs MW, de Graaff E, Sillevis Smitt PA, Hoogenraad CC. Detection and characterization of autoantibodies to neuronal cell-surface antigens in the central nervous system. Front Mol Neurosci. 2016;9:37.","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"1501_CR21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1468-1331.2010.02970.x","volume":"17","author":"I Steiner","year":"2010","unstructured":"Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2010;17(8):999\u2013e57.","journal-title":"Eur J Neurol"},{"issue":"4","key":"1501_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1501_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrrheum.2014.15","volume":"10","author":"JG Hanly","year":"2014","unstructured":"Hanly JG. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol. 2014;10(6):338\u201347.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1501_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","volume":"6","author":"A Al-Diwani","year":"2019","unstructured":"Al-Diwani A, Handel A, Townsend L, Pollak T, Leite MI, Harrison PJ, et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. 2019;6(3):235\u201346.","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"1501_CR25","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/ene.12911","volume":"23","author":"W Wang","year":"2016","unstructured":"Wang W, Li JM, Hu FY, Wang R, Hong Z, He L, et al. Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in Southwest China. Eur J Neurol. 2016;23(3):621\u20139.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1501_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63\u201374.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1501_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","volume":"13","author":"A van Sonderen","year":"2017","unstructured":"van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol. 2017;13(5):290\u2013301.","journal-title":"Nat Rev Neurol"},{"issue":"14","key":"1501_CR28","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1212\/WNL.0000000000004541","volume":"89","author":"D Escudero","year":"2017","unstructured":"Escudero D, Guasp M, Arino H, Gaig C, Martinez-Hernandez E, Dalmau J, et al. Antibody-associated CNS syndromes without signs of inflammation in the elderly. Neurology. 2017;89(14):1471\u20135.","journal-title":"Neurology."},{"issue":"8","key":"1501_CR29","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/ene.13324","volume":"24","author":"M Celicanin","year":"2017","unstructured":"Celicanin M, Blaabjerg M, Maersk-Moller C, Beniczky S, Marner L, Thomsen C, et al. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study. Eur J Neurol. 2017;24(8):999\u20131005.","journal-title":"Eur J Neurol"},{"issue":"2","key":"1501_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/brain\/awx323","volume":"141","author":"J Thompson","year":"2018","unstructured":"Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, et al. The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain. 2018;141(2):348\u201356.","journal-title":"Brain."},{"issue":"1","key":"1501_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24979","volume":"82","author":"A Gadoth","year":"2017","unstructured":"Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, et al. Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients. Ann Neurol. 2017;82(1):79\u201392.","journal-title":"Ann Neurol"},{"issue":"9","key":"1501_CR32","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/jnnp-2014-308814","volume":"86","author":"M Dogan Onugoren","year":"2015","unstructured":"Dogan Onugoren M, Deuretzbacher D, Haensch CA, Hagedorn HJ, Halve S, Isenmann S, et al. Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series. J Neurol Neurosurg Psychiatry. 2015;86(9):965\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1501_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/nyas.12553","volume":"1338","author":"F Leypoldt","year":"2015","unstructured":"Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci. 2015;1338:94\u2013114.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"1501_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ana.20614","volume":"58","author":"R Vitaliani","year":"2005","unstructured":"Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol. 2005;58(4):594\u2013604.","journal-title":"Ann Neurol"},{"issue":"12","key":"1501_CR35","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091\u20138.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1501_CR36","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/jamaneurol.2014.488","volume":"71","author":"GS Day","year":"2014","unstructured":"Day GS, Laiq S, Tang-Wai DF, Munoz DG. Abnormal neurons in teratomas in NMDAR encephalitis. JAMA Neurol. 2014;71(6):717\u201324.","journal-title":"JAMA Neurol"},{"key":"1501_CR37","doi-asserted-by":"crossref","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013.","DOI":"10.1016\/S1474-4422(12)70310-1"},{"issue":"2","key":"1501_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3988\/jcn.2014.10.2.157","volume":"10","author":"JA Lim","year":"2014","unstructured":"Lim JA, Lee ST, Jung KH, Kim S, Shin JW, Moon J, et al. Anti-N-methyl-d-aspartate receptor encephalitis in Korea: clinical features, treatment, and outcome. J Clin Neurol. 2014;10(2):157\u201361.","journal-title":"J Clin Neurol"},{"issue":"8","key":"1501_CR39","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1501_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ana.21756","volume":"66","author":"NR Florance","year":"2009","unstructured":"Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009;66(1):11\u20138.","journal-title":"Ann Neurol"},{"key":"1501_CR41","doi-asserted-by":"crossref","unstructured":"Varley JA, Webb AJS, Balint B, Fung VSC, Sethi KD, Tijssen MAJ, et al. The movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study. J Neurol Neurosurg Psychiatry. 2018.","DOI":"10.1136\/jnnp-2018-318584"},{"issue":"1\u20132","key":"1501_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0165-5728(02)00314-4","volume":"132","author":"S Shiraga","year":"2002","unstructured":"Shiraga S, Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol. 2002;132(1\u20132):72\u201382.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"1501_CR43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1600-0404.2011.01572.x","volume":"125","author":"O Stich","year":"2012","unstructured":"Stich O, Klages E, Bischler P, Jarius S, Rasiah C, Voltz R, et al. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes. Acta Neurol Scand. 2012;125(5):326\u201331.","journal-title":"Acta Neurol Scand"},{"key":"1501_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jneuroim.2016.04.004","volume":"295\u2013296","author":"B Berger","year":"2016","unstructured":"Berger B, Stich O, Labeit S, Rauer S. Screening for anti-titin antibodies in patients with various paraneoplastic neurological syndromes. J Neuroimmunol. 2016;295\u2013296:18\u201320.","journal-title":"J Neuroimmunol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1501-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T19:20:48Z","timestamp":1604517648000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1501-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1501"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1501-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.1811\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.1811\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.1811\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.1811\/v3","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]},"assertion":[{"value":"5 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval has been granted by the Ethics Committee of the Faculty of Medicine, Chulalongkorn University and KCMH, IRB number 329\/60.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}